Carotidynia after anticancer chemotherapy.
- Author:
Shinichi HAYASHI
1
;
Shuichiro MARUOKA
;
Noriaki TAKAHASHI
;
Shu HASHIMOTO
Author Information
1. Division of Respiratory Medicine, Nihon University School of Medicine, 30-1 Ohyaguchikamimachi, Itabashi-ku, Tokyo 173-8610, Japan. shayashi@med.nihon-u.ac.jp.
- Publication Type:Case Reports
- MeSH:
Antineoplastic Agents;
adverse effects;
Carotid Artery, Common;
drug effects;
pathology;
Granulocyte Colony-Stimulating Factor;
adverse effects;
Humans;
Inflammation;
chemically induced;
Lung Neoplasms;
drug therapy;
Magnetic Resonance Imaging;
Male;
Middle Aged;
Neoplasms;
drug therapy;
Taxoids;
adverse effects;
therapeutic use;
Tomography, X-Ray Computed;
Treatment Outcome;
Ultrasonography
- From:Singapore medical journal
2014;55(9):e142-4
- CountrySingapore
- Language:English
-
Abstract:
Carotidynia is characterised by inflammation limited to the common carotid artery, which has been recognised as a distinct disease entity by advanced vascular imaging. Although most cases of carotidynia are idiopathic, we herein present a case of carotidynia after anticancer chemotherapy. A 64-year-old male patient received docetaxel followed by granulocyte-colony stimulating factor (G-CSF) for the treatment of lung squamous carcinoma. After the treatment, bilateral cervical pain developed. Vascular imaging, including magnetic resonance imaging, computed tomography and ultrasonography, showed characteristics specific for carotidynia. Although there was no strong confirmation using tests such as a challenge test, our observations suggest that docetaxel or G-CSF could be a causative drug triggering carotidynia.
